Sera from 267 people who had lepromatous leprosy were also tested in the TPHA test. Fourteen sera were reactive in the TPHA, TPI, and FTA-ABS tests and were from people who had both syphilis and leprosy. Biological false positive reactions were shown by 26 of the leprosy sera, of which three or 11-5 % were also reactive in the TPHA test. A further four sera in the leprosy group were reactive only in the TPHA test.
The Table II Results of CWR, VDRL, and TPHA tests on 267 leprosy sera group.bmj.com on July 8, 2017 -Published by http://jcp.bmj.com/ Downloaded from probability false positive TPHA test results. The biological false positive sera were from people with no history or clinical evidence of syphilis and each serum gave a non-reactive TPI and FTA-ABS test result. The FTA-ABS test is the first to become reactive in early syphilis even before the reagin tests, and both TPI and FTA-ABS tests are reactive in secondary, latent, and late syphilis. It is therefore unlikely that these 31 sera were from patients with syphilis.
Both the pathogenic and non-pathogenic treponemes share common or group antibodies. In the TPHA test this group antibody is removed from the test serum by Reiter treponeme components which are present in the absorbing diluent used in the test. Reiter treponeme components are used similarly in the FTA-ABS test to remove group antibody. However, this has not always been completely successful (Kiraly, Jobbagy, and Kovafts, 1967) and some false reactive FTA-ABS test results will occur. Thus it seems highly probable that some false reactive TPHA test results could occur due to failure of the Reiter treponemes to remove all group antibody from the test serum.
The significance of TPHA test titres has not been generally determined. The authors in an earlier study (Gamer, Backhouse, Daskalopoulos, and Walsh, 1973) 
